COVID-19 全球风湿病联盟：大流行期间的数据收集。
The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic.
机构信息
University of Queensland Faculty of Medicine, Royal Brisbane Clinical Unit, Royal Brisbane Hospital, Brisbane, Australia.
Division of Rheumatology, University of California San Francisco, San Francisco, CA, USA.
出版信息
Nat Rev Rheumatol. 2020 Jun;16(6):293-294. doi: 10.1038/s41584-020-0418-0.
Abstract
The global COVID-19 pandemic has the potential to severely affect those with rheumatic diseases or who are taking immunosuppressive therapies. Information is lacking as to how these groups will fare if they become infected. A global alliance has rapidly formed to try to address this information deficit.
摘要
全球 COVID-19 大流行有可能严重影响风湿性疾病患者或正在接受免疫抑制治疗的患者。如果这些人群感染，他们的病情会如何尚不清楚。一个全球性的联盟已经迅速成立，试图解决这一信息缺口。
相似文献
1
The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic.COVID-19 全球风湿病联盟：大流行期间的数据收集。
Nat Rev Rheumatol. 2020 Jun;16(6):293-294. doi: 10.1038/s41584-020-0418-0.
2
Rheumatology in a time of Coronavirus: lessons from our early experiences.新冠疫情下的风湿病学：我们早期经验的教训
QJM. 2020 Oct 1;113(10):715-716. doi: 10.1093/qjmed/hcaa163.
3
Capturing Patient-Reported Outcomes During the COVID-19 Pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey.在2019冠状病毒病大流行期间收集患者报告的结果：2019冠状病毒病全球风湿病联盟患者体验调查的开发
Arthritis Care Res (Hoboken). 2020 Jul;72(7):871-873. doi: 10.1002/acr.24257.
4
Virtual rheumatology appointments during the COVID-19 pandemic: an international survey of perspectives of patients with rheumatic diseases.2019冠状病毒病大流行期间的虚拟风湿病门诊：一项关于风湿病患者观点的国际调查
Clin Rheumatol. 2020 Nov;39(11):3191-3193. doi: 10.1007/s10067-020-05338-3. Epub 2020 Aug 15.
5
How did COVID-19 pandemic changed the Portuguese rheumatology?新冠疫情如何改变了葡萄牙的风湿病学？
Acta Reumatol Port. 2020 Jun 8;45(Jan-Mar (1)):5-6.
6
The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance.风湿病学界对COVID-19大流行的应对：COVID-19全球风湿病联盟的成立。
Rheumatology (Oxford). 2020 Jun 1;59(6):1204-1206. doi: 10.1093/rheumatology/keaa191.
7
Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR.2019冠状病毒病大流行期间风湿病患者的护理：亚太风湿病学联盟的立场声明
Int J Rheum Dis. 2020 Jun;23(6):717-722. doi: 10.1111/1756-185X.13863. Epub 2020 May 27.
8
COVID-19 and cancer: Looking for evidence.新型冠状病毒肺炎与癌症：寻找证据
Eur J Surg Oncol. 2020 Jun;46(6):929-930. doi: 10.1016/j.ejso.2020.05.002. Epub 2020 May 6.
9
Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic.2019年冠状病毒病（COVID-19）大流行期间哈萨克斯坦儿科风湿病患者的管理
Rheumatol Int. 2020 Aug;40(8):1351-1352. doi: 10.1007/s00296-020-04613-5. Epub 2020 Jun 8.
10
Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic.意大利坎帕尼亚地区在新冠疫情期间的风湿病管理
Rheumatol Int. 2020 Sep;40(9):1537-1538. doi: 10.1007/s00296-020-04648-8. Epub 2020 Jul 14.
引用本文的文献
1
COVID-19 vaccine booster uptake and effectiveness among persons with systemic autoimmune and rheumatic diseases.2019冠状病毒病疫苗加强针在患有系统性自身免疫性和风湿性疾病人群中的接种情况及有效性
J Rheumatol. 2025 Aug 1. doi: 10.3899/jrheum.2025-0535.
2
Impact of the Coronavirus Disease 2019 Pandemic on Initiation Therapy for Noninfectious Uveitis.2019年冠状病毒病大流行对非感染性葡萄膜炎起始治疗的影响
Ophthalmol Sci. 2025 Jan 27;5(4):100718. doi: 10.1016/j.xops.2025.100718. eCollection 2025 Jul-Aug.
3
Clinical Characteristics, Prognostic Factors, and Outcomes of COVID-19 in Autoimmune Rheumatic Disease Patients: A Retrospective Case-Control Study from Astana, Kazakhstan.《哈萨克斯坦阿斯塔纳 COVID-19 自身免疫性风湿病患者的临床特征、预后因素和结局：一项回顾性病例对照研究》
Medicina (Kaunas). 2024 Aug 23;60(9):1377. doi: 10.3390/medicina60091377.
4
What the SARS-CoV-2 Pandemic Has Taught Us About Immunosuppression, Vaccinations, and Immune Dysregulation: The Rheumatology Experience.SARS-CoV-2 大流行让我们了解到免疫抑制、疫苗接种和免疫失调：风湿病学的经验。
Curr Allergy Asthma Rep. 2024 Apr;24(4):221-232. doi: 10.1007/s11882-024-01139-9. Epub 2024 Apr 3.
5
Developing Crowdsourced Clinical Registry Studies.开发众包临床注册研究。
Am J Nurs. 2024 Apr 1;124(4):36-41. doi: 10.1097/01.NAJ.0001010572.96486.87. Epub 2024 Mar 21.
6
COVID-19 Infection and Clinical Outcomes in Hospitalized Patients With Rheumatoid Arthritis: Insights From the National Inpatient Sample.类风湿关节炎住院患者的新冠病毒感染及临床结局：来自全国住院患者样本的见解
J Community Hosp Intern Med Perspect. 2024 Jan 12;14(1):5-12. doi: 10.55729/2000-9666.1288. eCollection 2024.
7
Omicron variant infection in inflammatory rheumatological conditions - outcomes from a COVID-19 naive population in Aotearoa New Zealand.奥密克戎变异株在炎症性风湿性疾病中的感染——来自新西兰奥特亚罗瓦未感染过新冠病毒人群的结果
Lancet Reg Health West Pac. 2023 Jul 18;38:100843. doi: 10.1016/j.lanwpc.2023.100843. eCollection 2023 Sep.
8
How Twitter use in Rheumatology has Evolved.风湿病学领域中推特的使用方式是如何演变的。
Rheumatol Immunol Res. 2022 Dec 31;3(4):153-155. doi: 10.2478/rir-2022-0027. eCollection 2022 Dec.
9
Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry.日本 COVID-19 合并基础风湿性疾病患者的临床特征：一项使用 COVID-19 全球风湿病联盟医生报告登记处的多中心观察性研究的数据。
Clin Rheumatol. 2022 Dec;41(12):3661-3673. doi: 10.1007/s10067-022-06305-w. Epub 2022 Aug 16.
10
Application of Monoclonal Antibody Drugs in Treatment of COVID-19: a Review.单克隆抗体药物在COVID-19治疗中的应用：综述
Bionanoscience. 2022;12(4):1436-1454. doi: 10.1007/s12668-022-00997-9. Epub 2022 Jun 15.
本文引用的文献
1
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.华盛顿州 21 例 COVID-19 危重症患者的特征和结局。
JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.
2
Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line.意大利应对新冠疫情——疫情前线的伦理、后勤与治疗
N Engl J Med. 2020 May 14;382(20):1873-1875. doi: 10.1056/NEJMp2005492. Epub 2020 Mar 18.
3
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
4
Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy.带状疱疹和托法替尼：临床结局和伴随治疗的风险。
Arthritis Rheumatol. 2017 Oct;69(10):1960-1968. doi: 10.1002/art.40189. Epub 2017 Sep 6.
5
A Comparative Study of Clinical Presentation and Risk Factors for Adverse Outcome in Patients Hospitalised with Acute Respiratory Disease Due to MERS Coronavirus or Other Causes.中东呼吸综合征冠状病毒或其他病因导致的急性呼吸道疾病住院患者的临床表现及不良结局危险因素的比较研究
PLoS One. 2016 Nov 3;11(11):e0165978. doi: 10.1371/journal.pone.0165978. eCollection 2016.
6
Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission.两例中东呼吸综合征冠状病毒感染的临床特征和病毒学诊断：一起医院感染传播的报告。
Lancet. 2013 Jun 29;381(9885):2265-72. doi: 10.1016/S0140-6736(13)60982-4. Epub 2013 May 30.
7
The risk of infections with biologic therapies for rheumatoid arthritis.类风湿关节炎生物治疗的感染风险。
Semin Arthritis Rheum. 2010 Apr;39(5):327-46. doi: 10.1016/j.semarthrit.2008.10.002. Epub 2008 Dec 31.
8
Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.大多伦多地区144例严重急性呼吸综合征患者的临床特征及短期预后
JAMA. 2003 Jun 4;289(21):2801-9. doi: 10.1001/jama.289.21.JOC30885. Epub 2003 May 6.
9
A major outbreak of severe acute respiratory syndrome in Hong Kong.香港爆发严重急性呼吸系统综合症。
N Engl J Med. 2003 May 15;348(20):1986-94. doi: 10.1056/NEJMoa030685. Epub 2003 Apr 7.
Zotero 插件